Synthesis and antibacterial activity of novel 4-{4-(methylamino)thieno[3,2-d]pyrimidin-2-yl}-benzohydrazide derivatives
摘要:
A series of novel 4-{4-(methylamino)thieno[3,2-d]pyrimidin-2-yl}benzohydrazide derivatives were synthesized and evaluated for their antibacterial activity. Most of the compounds demonstrated high activity towards Escherichia coli, Pseudomonas, Staphylococcus aureus, and Bacillus. Structures of all synthesized compounds were confirmed by spectral analysis.
[EN] PYRAZOLE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSYNE KINASES<br/>[FR] DERIVES DE PYRAZOLE EN TANT QU'INHIBITEURS DE RECEPTEUR TYROSINE KINASES
申请人:ASTRAZENECA AB
公开号:WO2005049033A1
公开(公告)日:2005-06-02
Compounds of formula (I): and their use in the inhibition of Trk activity are described.
化合物的化学式(I)及其在抑制Trk活性中的应用被描述。
Thiophene derivatives as chk 1 inhibitors
申请人:Ashwell Susan
公开号:US20070010556A1
公开(公告)日:2007-01-11
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
Pyrazole derivatives as inhibitors of receptor tyrosone kinases
申请人:Block Howard Michael
公开号:US20070142413A1
公开(公告)日:2007-06-21
Compounds of formula (I): and their use in the inhibition of Trk activity are described.
描述了式(I)的化合物及其在抑制Trk活性方面的用途。
PYRAZOLE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES
申请人:Block Michael Howard
公开号:US20100152219A1
公开(公告)日:2010-06-17
Compounds of formula (I): and their use in the inhibition of Trk activity are described.
描述了式(I)的化合物及其在抑制Trk活性方面的应用。
THIENOPYRIMIDINE DERIVATIVES AS P13K INHIBITORS
申请人:Hancox Timothy Colin
公开号:US20110021496A1
公开(公告)日:2011-01-27
Thienopyrimidines of formula (I) wherein W and R
1
to R
4
are as defined in the claims, and the pharmaceutically acceptable salts thereof are inhibitors of PI3K and are selective for the p110δ isoform, which is a class Ia PI3 kinase, over both other class Ia and class Ib kinases. The compounds may be used to treat diseases and disorders arising from abnormal cell growth, function or behaviour associated with PI3 kinase such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders.